Characterization of in vitro antibody-dependent cell-mediated cytotoxicity activity of therapeutic antibodies — Impact of effector cells
- 1 May 2014
- journal article
- Published by Elsevier in Journal of Immunological Methods
- Vol. 407, 63-75
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Which are the antibodies to watch in 2013?mAbs, 2013
- Quantitative evaluation of fucose reducing effects in a humanized antibody on Fcγ receptor binding and antibody-dependent cell-mediated cytotoxicity activitiesmAbs, 2012
- Development and validation of an antibody-dependent cell-mediated cytotoxicity-reporter gene assaymAbs, 2012
- Monoclonal antibodies for the treatment of cancerSeminars in Cancer Biology, 2012
- Advances in the assessment and control of the effector functions of therapeutic antibodiesNature Reviews Drug Discovery, 2011
- The state of the art: immune-mediated mechanisms of monoclonal antibodies in cancer therapyBritish Journal of Cancer, 2009
- Human natural killer cellsBlood, 2008
- Increased natural killer cell expression of CD16, augmented binding and ADCC activity to rituximab among individuals expressing the FcγRIIIa-158 V/V and V/F polymorphismBlood, 2007
- Fucose Depletion from Human IgG1 Oligosaccharide Enhances Binding Enthalpy and Association Rate Between IgG1 and FcγRIIIaJournal of Molecular Biology, 2004
- Cytotoxicity mediated by human Fc receptors for IgGImmunology Today, 1989